Abstract:The integration of reactive oxygen species (ROS)-involved molecular dynamic therapy (MDT) and photodynamic therapy (PDT) holds great promise for enhanced anticancer effects. Herein, we report a biodegradable tumor microenvironment-responsive nanoplatform composed of sinoporphyrin sodium (SPS) photosensitizer-loaded zinc peroxide nanoparticles (SPS@ZnO2 NPs), which can enhance the action of ROS through the production of hydrogen peroxide (H2O2) and singlet oxygen (1O2) for MDT and PDT, respectively, and the depletion of glutathione (GSH). Under these conditions, SPS@ZnO2 NPs show excellent MDT/PDT synergistic therapeutic effects. We demonstrate that the SPS@ZnO2 NPs quickly degrade to H2O2 and endogenous Zn2+ in an acidic tumor environment and produce toxic 1O2 with 630 nm laser irradiation both in vitro and in vivo. Anticancer mechanistic studies show that excessive production of ROS damages lysosomes and mitochondria and induces cellular apoptosis. We show that SPS@ZnO2 NPs increase the uptake and penetration depth of photosensitizers in cells. In addition, the fluorescence of SPS is a powerful diagnostic tool for the treatment of tumors. The depletion of intracellular GSH through H2O2 production and the release of cathepsin B enhance the effectiveness of PDT. This theranostic nanoplatform provides a new avenue for tumor microenvironment-responsive and ROS-involved therapeutic strategies with synergistic enhancement of antitumor activity.

GSH-Triggered/Photothermal-Enhanced H2S Signaling Molecule Release for Gas Therapy

Nanotherapeutics for Hydrogen Sulfide-Involved Treatment: an Emerging Approach for Cancer Therapy

Mesoporous Organosilica-Based Hydrogen Sulfide Nanogenerator for Enhanced Tumor Chemotherapy

Photoregulated plasmon enhanced controllable hydrogen sulfide delivery for photothermal augmented gas therapy

Development of Novel Hydrogen Sulfide Depletion Aided Platform for Photodynamic Therapy with Enhanced Anticancer Performance.

Tumor-Selective Biodegradation-Regulated Photothermal H2 S Donor for Redox Dyshomeostasis- and Glycolysis Disorder-Enhanced Theranostics.

Hydrogen Sulfide Delivery System Based on Salting-Out Effect for Enhancing Synergistic Photothermal and Photodynamic Cancer Therapies

Smart Lipid Nanoparticle that Remodels Tumor Microenvironment for Activatable H2S Gas and Photodynamic Immunotherapy

Biodegradable Hollow Mesoporous Organosilica Nanotheranostics for Mild Hyperthermia-Induced Bubble-Enhanced Oxygen-Sensitized Radiotherapy.

Depletion and Downregulation of Hydrogen Sulfide Using an Activatable Probe for Promoting Photothermal Therapy toward Colorectal Cancers

A multi-parameter-induced activation of gas therapeutic platform to remarkably amplify photodynamic therapy efficacy

ZnS@ZIF-8 Core-Shell Nanoparticles Incorporated with ICG and TPZ to Enable H2S-amplified Synergistic Therapy.

Glutathione-responsive biodegradable nanohybrid for cancer photoacoustic imaging and gas-assisted photothermal therapy

Tumor‐Selective Biodegradation‐Regulated Photothermal H 2 S Donor for Redox Dyshomeostasis‐ and Glycolysis Disorder‐Enhanced Theranostics (Small 8/2022)

Tumor‐Selective Biodegradation‐Regulated Photothermal H2S Donor for Redox Dyshomeostasis‐ and Glycolysis Disorder‐Enhanced Theranostics (small 8/2022)

A biodegradable calcium sulfite nanoreactor for pH triggered gas therapy in combination with chemotherapy

Tumor Microenvironment-Responsive Theranostic Nanoplatform for Guided Molecular Dynamic/Photodynamic Synergistic Therapy

Biodegradable calcium sulfide-based nanomodulators for H 2 S-boosted Ca 2+ -involved synergistic cascade cancer therapy

Glutathione-triggered release of SO2 gas to augment oxidative stress for enhanced chemodynamic and sonodynamic therapy

Sulourea-coordinated Pd nanocubes for NIR-responsive photothermal/H2S therapy of cancer

A Tumor‐Microenvironment‐Responsive Nanocomposite for Hydrogen Sulfide Gas and Trimodal‐Enhanced Enzyme Dynamic Therapy